Selected telomere length changes and aberrant three-dimensional nuclear telomere organization during fast-onset mouse plasmacytomas

Neoplasia

Volumn 14, Issue 4, 2012, Pages 344-351

  Kuzyk, Alexandra ^a   Mai, Sabine ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CHROMOSOME 11; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; IMAGING AND DISPLAY; INTERPHASE; METAPHASE; MOUSE; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION; TELOMERE; THREE DIMENSIONAL IMAGING; TWO DIMENSIONAL IMAGING;

EID: 84860631637     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.12446     Document Type: Article

References (62)

1. Olovnikov AM (1972). The immune response and the process of marginotomy in lymphoid cells. Vestn Akad Med Nauk SSSR 27, 85-87.
2. Watson JD (1972). Origin of concatemeric T7 DNA. Nat New Biol 239, 197-201.
3. Hayflick L and Moorhead PS (1961). The serial cultivation of human diploid cell strains. Exp Cell Res 25, 585-621.
4. Harley CB, Futcher AB, and Greider CW (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460.
5. Deng Y, Chan SS, and Chang S (2008). Telomere dysfunction and tumor suppression: the senescence connection. Nat Rev Cancer 8, 450-458.
6. Collins K and Mitchell JR (2002). Telomerase in the human organism. Oncogene 21, 564-579.
7. Misri S, Pandita S, Kumar R, and Pandita TK (2008). Telomeres, histone code, and DNA damage response. Cytogenet Genome Res 122, 297-307.
8. Lansdorp PM (2009). Telomeres and disease. EMBO J 28, 2532-2540.
9. Zvereva MI, Shcherbakova DM, and Dontsova OA (2010). Telomerase: structure, functions and activity regulation. Biochemistry (Mosc) 75, 1563-1583.
10. Greider CW and Blackburn EH (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413.
11. Blackburn EH (2001). Switching and signaling at the telomere. Cell 106, 661-673.
12. Xu L and Blackburn EH (2007). Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres. Mol Cell 28, 315-327.
13. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, and Reddel RR (1997). Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3, 1271-1274.
14. Dunham MA, Neumann AA, Fasching CL, and Reddel RR (2000). Telomere maintenance by recombination in human cells. Nat Genet 26, 447-450.
15. Muntoni A and Reddel RR (2005). The first molecular details of ALT in human tumor cells. Hum Mol Genet 14, R191-R196.
16. Cesare AJ and Reddel RR (2010). Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11, 319-330.
17. Odagiri E, Kanada N, Jibiki K, Demura R, Aikawa E, and Dumura H (1994). Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer 73, 2978-2984.
18. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, and De Marzo AM (2004). Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 10, 3317-3326.
19. Rampazzo E, Bertorelle R, Serra L, Terrin L, Candiotto C, Pucciarelli S, Del Blanco P, Nitti D, and De Rossi A (2010). Relationship between telomere shortening, genetic instability, and site of tumor origin in colorectal cancers. Br J Cancer 102, 1300-1305.
20. Hanahan D and Weinberg RA (2000). The hallmarks of cancer. Cell 100, 57-70.
21. Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, Hoglund M, Mitelman F, Mertens F, and Mandahl N (2001). Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci USA 98, 12683-12688.
22. Hanahan D and Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
23. Murnane JP and Sabatier L (2004). Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bioessays 26, 1164-1174.
24. Louis SF, Vermolen BJ, Garini Y, Young IT, Guffei A, Lichtensztejn Z, Kuttler F, Chuang TC, Moshir S, Mougey V, et al. (2005). c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 102, 9613-9618.
25. Mai S and Garini Y (2005). Oncogenic remodeling of the three-dimensional organization of the interphase nucleus: c-Myc induces telomeric aggregates whose formation precedes chromosomal rearrangements. Cell Cycle 4, 1327-1331.
26. Mai S (2010). Initiation of telomere-mediated chromosomal rearrangement in cancer. J Cell Biochem 109, 1095-1102.
27. Guffei A, Sarkar R, Klewes L, Righolt C, Knecht H, and Mai S (2010). Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles. Haematologica 95, 2038-2046.
28. Martinez P and Blasco MA (2011). Telomeric and extratelomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11, 161-176.
29. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, and Greider CW (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34.
30. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, and DePinho RA (1999). Longevity, stress response, and cancer in aging telomerasedeficient mice. Cell 96, 701-712.
31. Willeit P, Willeit J, Brandstatter A, Ehrlenbach S, Mayr A, Gasperi A, Weger S, Oberhollenzer F, Reindl M, Kronenberg F, et al. (2010). Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 30, 1649-1656.
32. Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska V, Little MT, Dirks RW, Raap AK, and Tanke HJ (1996). Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5, 685-691.
33. Martens UM, Zijlmans JM, Poon SS, Dragowska W, Yui J, Chavez EA, Ward RK, and Lansdorp PM (1998). Short telomeres on human chromosome 17p. Nat Genet 18, 76-80.
34. Baird DM, Rowson J, Wynford-Thomas D, and Kipling D (2003). Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat Genet 33, 203-207.
35. Britt-Compton B, Rowson J, Locke M, Mackenzie I, Kipling D, and Baird DM (2006). Structural stability and chromosome-specific telomere length is governed by cis-acting determinants in humans. Hum Mol Genet 15, 725-733.
36. Xing J, Ajani JA, Chen M, Izzo J, Lin J, Chez Z, Gu J, and Wu X (2009). Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res (Phila) 2, 459-465.
37. Samassekou O, Ntwari A, Hebert J, and Yan J (2009). Individual telomere lengths in chronic myeloid leukemia. Neoplasia 11, 1146-1154.
38. Samassekou O, Li H, Hebert J, Ntwari A, Wang H, Cliché CG, Bouchard E, Huang S, and Yan J (2011). Chromosome arm-specific long telomeres: a new clonal event in primary chronic myelogenous leukemia cells. Neoplasia 13, 550-560.
39. Zheng YL, Loffredo CA, Shields PG, and Selim SM (2009). Chromosome 9 armspecific telomere length and breast cancer risk. Carcinogenesis 30, 1380-1386.
40. Adams JM, Gerondakis S, Webb E, Corcoran LM, and Cory S (1983). Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci USA 80, 1982-1986.
41. Wiener F, Coleman A, Mock BA, and Potter M (1995). Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus. Cancer Res 55, 1181-1188.
42. Wiener F, Schmalter AK, Mowat MR, and Mai S (2010). Duplication of subcytoband 11E2 of chromosome 11 is regularly associated with accelerated tumor development in v-abl/myc-induced mouse plasmacytomas. Genes Cancer 1, 847-858.
43. Hande P, Slijepcevic P, Silver A, Bouffler S, van Buul P, Bryant P, and Lansdorp P (1999). Elongated telomeres in SCID mice. Genomics 56, 221-223.
44. Hemann MT and Greider CW (2000). Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res 28, 4474-4478.
45. Potter M and Wiener F (1992). Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis 13, 1681-1697.
46. Chuang TC, Moshir S, Garini Y, Chuang AY, Young IT, Vermolen B, van den Doel R, Mougey V, Perrin M, Braun M, et al. (2004). The threedimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 3, 12.
47. Caporali A, Wark L, Vermolen BJ, Garini Y, and Mai S (2007). Telomeric aggregates and end-to-end chromosomal fusions require myc box II. Oncogene 26, 1398-1406.
48. Mai S and Wiener F (2002). The impact of p53 loss on murine plasmacytoma development. Chromosome Res 10, 239-251.
49. Schaefer LH, Schuster D, and Herz H (2001). Generalized approach for accelerated maximum likelihood based image restoration applied to three-dimensional fluorescence microscopy. J Microsc 204(pt 2), 99-107.
50. Vermolen BJ, Garini Y, Mai S, Mougey V, Fest T, Chuang TC, Chuang AY, Wark L, and Young IT (2005). Characterizing the three-dimensional organization of telomeres. Cytometry A 67, 144-150.
51. Poon SS, Martens UM, Ward RK, and Lansdorp PM (1999). Telomere length measurements using digital fluorescence microscopy. Cytometry 36, 267-278.
52. Mai S and Garini Y (2006). The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 97, 904-915.
53. Gadji M, Fortin D, Tsanaclis AM, Garini Y, Katzir N, Wienburg Y, Yan J, Klewes L, Klonisch T, Drouin R, et al. (2010). Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients. Neoplasia 12, 183-191.
54. Knecht H, Sawan B, Lichtensztejn D, Lemieux B, Wellinger RJ, and Mai S (2009). The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells. Leukemia 23, 565-573.
55. Knecht H, Bruderlein S, Wegener S, Lichtensztejn D, Lichtensztejn Z, Lemieux B, Moller P, and Mai S (2010. 3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps". BMC Cell Biol 11, 99.
56. Klewes L, Hobsch C, Katzir N, Rourke D, Garini Y, and Mai S (2011). Novel automated three-dimensional genome scanning based on the nuclear architecture of telomeres. Cytometry A 79, 159-166.
57. Gadji M, Awe JA, Rodriguez P, Klewes L, Kumar R, Houston DS, Falcao RP, de Oliveira FM, and Mai S (2012). Three-dimensional nuclear telomeric architecture defines cytopenias of myelodysplastic syndrome and its transformation to acute myeloid leukemia. In Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research, 2012 March 31-April 4, Chicago, Illinois. Philadelphia, PA: AACR. Abstract nr 2044.
58. Koelsch BU, Rajewsky MF, and Kindler-Rohrborn A (2005). A 6-MB contigbased comparative gene and linkage map of the rat schwannoma tumor suppressor region at 10q32.3. Genomics 85, 322-329.
59. Montagna C, Lyu MS, Hunter K, Lukes L, Lowther W, Reppert T, Hissong B, Weaver Z, and Ried T (2003). The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 63, 2179-2187.
60. Russell SE, McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Petty EM, Kalikin LM, Church SW, McIlroy S, Harkin DP, et al. (2000). Isolation and mapping of human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors. Cancer Res 60, 4729-4734.
61. Langan JE, Cole CG, Huckle EJ, Byrne S, McRonald FE, Rowbottom L, Ellis A, Shaw JM, Leigh IM, Kelsell DP, et al. (2004). Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region of 17q25 to 42.5 kb: sequence does not identify the causative gene. Hum Genet 114, 534-540.
62. Turhan N, Yurur-Kutlay N, Topcuoglu P, Sayki M, Yuksel M, Gurman G, and Tukun A (2006). Translocation (13;17)(q14;q25) as a novel chromosomal abnormality in acute myeloid leukemia-M4. Leuk Res 30, 903-905.